Evidence map›Paper›PMID 34503222›Full record

ArticleCancers2021

DHX30 Coordinates Cytoplasmic Translation and Mitochondrial Function Contributing to Cancer Cell Survival.

Bartolomeo Bosco, Annalisa Rossi, Dario Rizzotto, Meriem Hadjer Hamadou, Alessandra Bisio, Sebastiano Giorgetta, Alicia Perzolli, Francesco Bonollo, Angeline Gaucherot, Frédéric Catez and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Endonuclease G promotes hepatic mitochondrial respiration by selectively increasing mitochondrial tRNAProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Bartolomeo BoscoDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.
Annalisa RossiDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.ORCID 0000-0001-8750-4575
Dario RizzottoDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.ORCID 0000-0003-0106-7496
Meriem Hadjer HamadouDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.
Alessandra BisioDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.ORCID 0000-0002-3326-1923
Sebastiano GiorgettaDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.
Alicia PerzolliDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.ORCID 0000-0003-1302-0943
Francesco BonolloDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.ORCID 0000-0003-3609-5956
Angeline GaucherotInserm U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Université de Lyon 1, Centre Léon Bérard, F-69008 Lyon, France.
Frédéric CatezInserm U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Université de Lyon 1, Centre Léon Bérard, F-69008 Lyon, France.ORCID 0000-0001-8255-9091
Jean-Jacques DiazInserm U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Université de Lyon 1, Centre Léon Bérard, F-69008 Lyon, France.
Erik DassiDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.ORCID 0000-0003-4487-0449
Alberto IngaDepartment of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123 Trento, Italy.ORCID 0000-0002-8767-1637
University of Trento · ITUniversité Claude Bernard Lyon 1 · FR

Funding

Agence Nationale de la Recherche ActiMeth ANR-19-CE12-0004 to JJ DiazAgence Nationale de la Recherche ANR, grant RiboCard ANR-18-CE11-0020 to JJ DiazAssociazione Italiana per la Ricerca sul Cancro IG grant #18985 to A IngaInstitut National Du Cancer INCa, grant PRT-K program n°2018-024 EMT-CoNCEPT to JJ Diaz
6 · The paper itself

Abstract

DHX30 was recently implicated in the translation control of mRNAs involved in p53-dependent apoptosis. Here, we show that DHX30 exhibits a more general function by integrating the activities of its cytoplasmic isoform and of the more abundant mitochondrial one. The depletion of both DHX30 isoforms in HCT116 cells leads to constitutive changes in polysome-associated mRNAs, enhancing the translation of mRNAs coding for cytoplasmic ribosomal proteins while reducing the translational efficiency of the nuclear-encoded mitoribosome mRNAs. Furthermore, the depletion of both DHX30 isoforms leads to higher global translation but slower proliferation and lower mitochondrial energy metabolism. Isoform-specific silencing supports a role for cytoplasmic DHX30 in modulating global translation. The impact on translation and proliferation was confirmed in U2OS and MCF7 cells. Exploiting RIP, eCLIP, and gene expression data, we identified fourteen mitoribosome transcripts we propose as direct DHX30 targets that can be used to explore the prognostic value of this mechanism in cancer. We propose that DHX30 contributes to cell homeostasis by coordinating ribosome biogenesis, global translation, and mitochondrial metabolism. Targeting DHX30 could, thus, expose a vulnerability in cancer cells.

Indexed as

DHX30mitoribosomepolysomal profilingribosome biogenesisRNA binding proteinstranslation efficiency

Identifiers

PMID34503222
PMCPMC8430983
OpenAlexW3196645864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.